Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207503 · ClinicalTrials.gov registry record
Neurobehavioral Mechanisms of Emotion Regulation in Depression Across the Adult Lifespan
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 296
- Enrollment target
NCT03207503: Completed study, sponsored by Duke University.
NCT03207503 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 296 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03207503 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 296 participants
- Enrollment target
Study Summary
The aim of this study is to test a model of demographic (age, sex), clinical, cognitive, and neurocircuitry predictors of emotion regulation ability and long-term depressive symptoms.
Primary Outcome
Self-reported negative affect and arousal following the use of reappraisal and distraction strategies
Interventions
- PROCEDURE fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 296 participants |
| Start Date | 2017-10-10 |
| Est. Completion | 2023-11-20 |
What the finished NCT03207503 record still lists
NCT03207503 is an observational study that tracks outcomes without assigning an intervention. The registered 296 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which fMRI is the first listed.
NCT03207503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03207503 about?
NCT03207503 is a clinical study titled "Neurobehavioral Mechanisms of Emotion Regulation in Depression Across the Adult Lifespan". The aim of this study is to test a model of demographic (age, sex), clinical, cognitive, and neurocircuitry predictors of emotion regulation ability and long-term depressive symptoms.
What is the current status of trial NCT03207503?
This trial is currently completed. The enrollment target is 296 participants. The study started on 2017-10-10. Estimated completion is 2023-11-20.
What interventions are being tested in trial NCT03207503?
The interventions under investigation include: fMRI (PROCEDURE).
Who is sponsoring clinical trial NCT03207503?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05563792 · 296 participants · NA
Options for Pain Management Using Nonpharmacological Strategies
- NCT06828445 · 296 participants · Phase 1
Increasing Affordable Fruits and Vegetables for Families With Food Insecurity
- NCT06920563 · 296 participants · NA
Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI